The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting and adjournment of AGM

24 Nov 2020 07:00

RNS Number : 2360G
InnovaDerma PLC
24 November 2020
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Notice of General Meeting and adjournment of AGM

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, announces that it has posted to shareholders a notice convening a general meeting of the Company (the "General Meeting") to be held on 16 December 2020 at 10am (GMT). As previously announced on 23 October 2020, the General Meeting has been called as a result of a requisition notice from Edale Capital LLP.

 

Annual General Meeting

 

InnovaDerma also wishes to confirm that the AGM scheduled for 10am on 11 November 2020 has been adjourned to the same date and time as the General Meeting (i.e. 10am on 16 December 2020). A formal notice relating to the adjourned AGM has also been posted to shareholders.

 

Proxies that have been submitted for the AGM will remain valid for the adjourned AGM and you do not need to submit a new proxy unless you wish to change how your proxy should vote. However, you may continue to submit a proxy for the AGM up until 10 am (GMT) on 14 December 2020.

 

Virtual Arrangements

 

Given current measures around the COVID-19 situation and the desire of the Company to protect the health and safety of Shareholders, the General Meeting and the AGM will be run as virtual meetings. In order to ensure that shareholders are able to follow the proceedings of the General Meeting and AGM, the Company will provide access to an online audio and presentation link, accessible via the online Investor Meet Company platform. Shareholders that wish to attend the General Meeting and the AGM should register for the event in advance via the following link: https://www.investormeetcompany.com/innovaderma-plc/register-investor.

 

Shareholders are invited to submit any questions for the Board to consider in respect of the business of the General Meeting or the AGM. Questions should be submitted by email by sending them to agminnovaderma@tbcardew.com by 5pm on 3 December 2020 under the title "InnovaDerma Shareholder Questions" and should include any shareholder's full name. A selection of key questions (relating to the business of the General Meeting or the AGM) and the Company's responses will be posted on the Company's website by close of business on 8 December 2020 so that shareholders may review these before confirming their proxy vote. 

 

In accordance with Listing Rule 9.6.1, a copy of the General Meeting notice and notice in respect of the adjourned AGM has been submitted to the National Storage Mechanism and will shortly be available to view on the Company's website at https://www.innovaderma.com/company-publications/

Further enquiries

 

InnovaDerma

Joe Bayer

Blake Hughes

 

 

+61 417 870 743

c/o TB Cardew

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGFLFLDLELVFII
Date   Source Headline
12th Jan 20227:00 amRNSTrading Update
6th Jan 20222:06 pmRNSSecond Price Monitoring Extn
6th Jan 20222:01 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAcquisition of Remaining Shareholding - Skinny Tan
24th Dec 202112:44 pmRNSHolding(s) in Company
24th Dec 202112:41 pmRNSDirector/PDMR Shareholding
23rd Dec 20211:22 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20219:10 amRNSFinal Results
6th Dec 20217:00 amRNSJV established to accelerate growth of Prolong
22nd Oct 20217:00 amRNSExtension to Annual Report & Accounts Publication
12th Oct 20217:00 amRNSAppointment of Skinny Tan brand ambassador
16th Sep 202111:17 amRNSDirector/PDMR Shareholding
15th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20216:24 pmRNSHolding(s) in Company
7th Sep 202110:35 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSCorporate Update
8th Jul 20217:00 amRNSTrading Statement
5th Jul 20217:00 amRNSChange of Auditor
11th May 20216:15 pmRNSDirector/PDMR Shareholding
7th May 202111:05 amRNSSecond Price Monitoring Extn
7th May 202111:00 amRNSPrice Monitoring Extension
4th May 20215:12 pmRNSHolding(s) in Company
29th Apr 202112:24 pmRNSResult of Open Offer and General Meeting
29th Apr 20217:00 amRNSGeneral Meeting and Trading Statement
19th Apr 20214:41 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 202111:00 amRNSDirector/PDMR Shareholding
12th Apr 20216:19 pmRNSPublication of Prospectus
12th Apr 20217:00 amRNSExpected Timetable of Events
31st Mar 20217:00 amRNSInterim Results
22nd Mar 20212:25 pmRNSNotice of Results, Prospectus and General Meeting
24th Feb 20215:09 pmRNSForm 8.3 - Offeree Innovaderma
24th Feb 20214:47 pmRNSForm 8.3 - InnovaDerma PLC
23rd Feb 20211:51 pmRNSForm 8.3 - InnovaDerma PLC
22nd Feb 20214:48 pmRNSForm 8.3 - Innovaderma
19th Feb 20214:13 pmRNSForm 8.3 - Innovaderma PLC
18th Feb 20217:00 amRNSForm 8.3 - InnovaDerma PLC
17th Feb 20215:23 pmRNSForm 8.3 - InnovaDerma PLC
17th Feb 202112:37 pmRNSForm 8.3 - InnovaDerma
16th Feb 20216:23 pmRNSForm 8.3 - InnovaDerma PLC
16th Feb 202112:33 pmRNSForm 8.3 - InnovaDerma
16th Feb 202110:52 amRNSForm 8.3 - Innovaderma Plc
16th Feb 202110:06 amRNSForm 8.3 - Innovaderma PLC
16th Feb 20219:05 amBUSForm 8.3 - INNOVADERMA PLC - AMENDMENT
15th Feb 20216:12 pmRNSForm 8.3 - InnovaDerma
15th Feb 20215:03 pmRNSForm 8.3 - InnovaDerma Plc
15th Feb 20215:02 pmRNSHolding(s) in Company
15th Feb 20214:47 pmRNSForm 8 (OPD) - InnovaDerma plc
15th Feb 20213:40 pmRNSForm 8.3 - InnovaDerma PLC
15th Feb 20212:54 pmRNSForm 8.3 - InnovaDerma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.